ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver transplantation"

  • 2017 American Transplant Congress

    A Multi-Center Experience of Direct Acting Anti-Viral Agents in HCV Positive Patients Receiving HCV Positive Livers.

    N. Kapila,1 B. Zervos,2 B. Ismail,1 C. Lindenmeyer,3 V. Sanghi,3 K. Menon,3 G. Schnickel,2 J. Rivas,2 D. Reino,2 A. Tzakis.2

    1Gastroenterology, Cleveland Clinic, Weston, FL; 2Transplant, Cleveland Clinic, Weston, FL; 3Gastroenterology, Cleveland Clinic, Cleveland, OH

    Background: HCV cirrhosis is the leading indication for liver transplantation in the U.S. The development of direct acting anti-viral agents (DAAs) has changed the approach…
  • 2017 American Transplant Congress

    Results of the Initial Phase of the Portable Organ Care System (OCS™) Liver PROTECT Pivotal Trial.

    J. Markmann,1 M. Ghobrial,3 J. Magliocca,4 A. Demetris,5 M. Abouljoud.2

    1Department of Surgery-Division of Transplantation, Massachusetts General Hospital, Boston, MA; 2Transplant Institute and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI; 3Sherrie & Alan Conover Center for Liver Disease & Transplantation, Houston Methodist Hospital, Houston, TX; 4Division of Transplant Surgery Department of Surgery, The Emory Transplant Center, Atlanta, GA; 5Department of Transplant Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA

    PurposeThe OCS Liver PROTECT Trial is a prospective, international, randomized controlled trial to evaluate the impact of using portable ex-vivo warm, oxygenated blood perfusion using…
  • 2017 American Transplant Congress

    The Objective Liver Frailty Index Significantly Improves the Clinician “Eyeball Test” to Predict Mortality in Liver Transplant Candidates.

    J. Lai, K. Covinsky, C. McCulloch, S. Feng.

    UCSF, San Francisco

    Background: Frailty is a critical determinant of waitlist outcomes. The most commonly-used test to assess frailty in liver transplant (LT) candidates is the “eyeball test”,…
  • 2017 American Transplant Congress

    Liver Mesenchymal Stem Cells Inhibit T Cell Alloresponses.

    T. Taner, M. Gustafson, M. Hansen, A. Dietz, M. Stegall.

    Mayo Clinic, Rochester, MN

    Clinical and histologic evidence suggest that the liver allograft induces alloimmune hyporesponsiveness in the recipient. Mesenchymal stem cells (MSC) are multipotent non-hematopoietic stromal cells with…
  • 2017 American Transplant Congress

    Is There Any Difference Between ABO-Incompatible and ABO-Compatible Liver Transplantation? Oncologic Aspect.

    J. Lee,1 J. Lee,1 S. Song,1 S.-K. Kwon,1 D. Kim,1 J. Lee,2 M. Kim,1 G. Choi,1 J. Choi,1 D. Han,1 S. Kim,1 D. Joo.1

    1Department of Surgery, Yonsei University College of Medicine, Seoul, Korea; 2Department of Surgery, CHA University, Bundang, Korea

    Introduction: Liver transplantation (LT) is increasing treatment option for hepatocellular carcinoma (HCC) in East Asia. Over-immunosuppression is risk factor for oncologic outcome after transplantation and…
  • 2017 American Transplant Congress

    Epidemiology and Clinical Outcomes of Mycobacterium tuberculosis in Liver Transplant Recipients in an Intermediate Tuberculosis-Endemic Area.

    S. Kim,1 Y. Kim,1 J. Choi,2 S. Yoon,2 J. Kim,3 I. Moon,3 Y. Yoo,3 D. Kim.3

    1Infectious Disease, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea; 2Hepatology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea; 3Surgery, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea

    BackgroundSolid organ transplant recipients are considered a high risk group for Mycobacterium tuberculosis(TB). In Korea, the incidence of tuberculosis was estimated to be 80 per…
  • 2017 American Transplant Congress

    Combined Endoscopic and Percutaneous Cholangiography for Biliary Anastomotic Stricture in Adult Right-Lobe Living-Donor Liver Transplantation.

    A. Thorat,1 W.-H. Huang,2 C.-J. Yu,2 C.-Y. Peng,2 H.-R. Yang,1 C.-C. Yeh,1 T.-H. Chen,1 S.-C. Hsu,1 L.-B. Jeng.1

    1Organ Transplantation, China Medical University Hospital, Taichung, Taiwan; 2Internal Medicine, China Medical University Hospital, Taichung, Taiwan

    Background:Biliary anastomotic stricture isthe most common biliary complication after living donor liver transplantation (LDLT) that may be potentially life threatening if biliary sepsis occurs.Endoscopic retrograde…
  • 2017 American Transplant Congress

    Technique and Result of Anastomosing Right Hepatic Vein to Inferior Vena Cava with a Separate Cavotomy Inferior to Right Hepatic Vein Orfice.

    R. Rai, E. Trivedi, I. Shaikh, S. Nagral, N. Doctor.

    HPB & Transplant Surgery, Fortis Hospital, Mulund, Mumbai, Maharashtra, India

    From January 2013 to February 2016 total of 21 patients underwent consecutive Living Donor Liver Transplant in our center. All patients were transplanted using right…
  • 2017 American Transplant Congress

    Gastrointestinal Perforation After Liver Transplantation in Pediatric Patients.

    M. Kirnap,1 S. Yildirim,1 G. Moray,1 A. Torgay,2 M. Haberal.1

    1General Surgery and Transplantation, Baskent University, Ankara, Turkey; 2Anesthesiology, Baskent University, Ankara, Turkey

    Introduction: The improved surgical techniques, antirejection treatment, and postoperative management have made liver transplantation (LT) the treatment of choice for pediatric patients with end-stage liver…
  • 2017 American Transplant Congress

    Trends in Liver Transplantation Among Older Adults with ESLD.

    C. Haugen,1 Q. Huang,2 M. Pozo,1 M. McAdams-DeMarco,2 D. Segev.1,2

    1Surgery, JHU, Baltimore; 2Epidemiology, JHU, Baltimore

    As the population ages and as the average age of liver transplant (LT) waitlist candidates increases, understanding of the trends and outcomes is imperative for…
  • « Previous Page
  • 1
  • …
  • 122
  • 123
  • 124
  • 125
  • 126
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences